• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对32个西班牙乳腺癌和/或卵巢癌家族的BRCA1和BRCA2基因进行分子分析。

Molecular analysis of the BRCA1 and BRCA2 genes in 32 breast and/or ovarian cancer Spanish families.

作者信息

Osorio A, Barroso A, Martínez B, Cebrián A, San Román J M, Lobo F, Robledo M, Benítez J

机构信息

Department of Genetics, Fundación Jiménez Díaz, Madrid, Spain.

出版信息

Br J Cancer. 2000 Apr;82(7):1266-70. doi: 10.1054/bjoc.1999.1089.

DOI:10.1054/bjoc.1999.1089
PMID:10755399
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2374482/
Abstract

It is estimated that about 5-10% of breast cancer cases may be due to inherited predisposition. Until now, two main susceptibility genes have been identified: BRCA1 and BRCA2. The first linkage and mutational studies suggested that mutations in these two genes would account for the majority of high-risk breast cancer families, but recent studies show how the proportion of families due to BRCA1 or BRCA2 mutations strongly depends on the population and the types of family analyzed. It is now clear that, in the context of families with a modest cancer profile, which are the most commonly found in the clinical practice, the percentage of mutations found is much lower than that suggested by the first studies. In the present study, we analyze a group of 32 Spanish families, which contained at least three cases of female breast cancer (at least one of them diagnosed before the age of 50 years), for the presence of mutations in the BRCA genes. The total proportion of mutations was low (25%), although the percentage of mutations in the BRCA1 and BRCA2 genes was higher, considering the breast and ovarian cancer families and the male breast cancer families respectively. Our results are in agreement with the idea that a great proportion of moderate-risk cancer families could be due to low penetrance susceptibility genes distinct from BRCA1 or BRCA2.

摘要

据估计,约5%-10%的乳腺癌病例可能归因于遗传易感性。到目前为止,已确定了两个主要的易感基因:BRCA1和BRCA2。最初的连锁和突变研究表明,这两个基因的突变将占大多数高危乳腺癌家族的病因,但最近的研究表明,由BRCA1或BRCA2突变导致的家族比例在很大程度上取决于所分析的人群和家族类型。现在很清楚,在临床实践中最常见的癌症情况较为温和的家族中,发现的突变百分比远低于最初研究所表明的比例。在本研究中,我们分析了一组32个西班牙家族,这些家族中至少有三例女性乳腺癌(其中至少有一例在50岁之前被诊断出),以检测BRCA基因中是否存在突变。尽管分别考虑乳腺癌和卵巢癌家族以及男性乳腺癌家族时,BRCA1和BRCA2基因的突变百分比更高,但总的突变比例较低(25%)。我们的结果与以下观点一致,即很大一部分中度风险的癌症家族可能归因于不同于BRCA1或BRCA2的低外显率易感基因。

相似文献

1
Molecular analysis of the BRCA1 and BRCA2 genes in 32 breast and/or ovarian cancer Spanish families.对32个西班牙乳腺癌和/或卵巢癌家族的BRCA1和BRCA2基因进行分子分析。
Br J Cancer. 2000 Apr;82(7):1266-70. doi: 10.1054/bjoc.1999.1089.
2
Mutational analysis of the BRCA1-interacting genes ZNF350/ZBRK1 and BRIP1/BACH1 among BRCA1 and BRCA2-negative probands from breast-ovarian cancer families and among early-onset breast cancer cases and reference individuals.对来自乳腺癌-卵巢癌家族的BRCA1和BRCA2阴性先证者、早发性乳腺癌病例及对照个体中与BRCA1相互作用的基因ZNF350/ZBRK1和BRIP1/BACH1进行突变分析。
Hum Mutat. 2003 Aug;22(2):121-8. doi: 10.1002/humu.10238.
3
Analysis of BRCA1 and BRCA2 genes in Spanish breast/ovarian cancer patients: a high proportion of mutations unique to Spain and evidence of founder effects.西班牙乳腺癌/卵巢癌患者中BRCA1和BRCA2基因分析:西班牙特有的高比例突变及奠基者效应证据
Hum Mutat. 2003 Oct;22(4):301-12. doi: 10.1002/humu.10260.
4
Ten novel BRCA1 and BRCA2 mutations in breast and/or ovarian cancer families from northern Germany.来自德国北部乳腺癌和/或卵巢癌家族中的十种新型BRCA1和BRCA2突变
Hum Mutat. 2000 Dec;16(6):529-30. doi: 10.1002/1098-1004(200012)16:6<529::AID-HUMU14>3.0.CO;2-K.
5
Germline mutations in the BRCA1 and BRCA2 genes in Turkish breast/ovarian cancer patients.土耳其乳腺癌/卵巢癌患者BRCA1和BRCA2基因的种系突变
Hum Mutat. 2003 Apr;21(4):444-5. doi: 10.1002/humu.9119.
6
Incidence of BRCA1 and BRCA2 mutations in 54 Chilean families with breast/ovarian cancer, genotype-phenotype correlations.54个智利乳腺癌/卵巢癌家族中BRCA1和BRCA2突变的发生率及基因型-表型相关性
Breast Cancer Res Treat. 2006 Jan;95(1):81-7. doi: 10.1007/s10549-005-9047-1. Epub 2005 Oct 27.
7
The frequency of germ-line mutations in the breast cancer predisposition genes BRCA1 and BRCA2 in familial prostate cancer. The Cancer Research Campaign/British Prostate Group United Kingdom Familial Prostate Cancer Study Collaborators.家族性前列腺癌中乳腺癌易感基因BRCA1和BRCA2的种系突变频率。癌症研究运动/英国前列腺癌研究组英国家族性前列腺癌研究协作组。
Cancer Res. 2000 Aug 15;60(16):4513-8.
8
A high occurrence of BRCA1 and BRCA2 mutations among Czech hereditary breast and breast-ovarian cancer families.捷克遗传性乳腺癌和乳腺-卵巢癌家族中BRCA1和BRCA2突变的高发生率。
Cas Lek Cesk. 2000 Oct 11;139(20):635-7.
9
Characteristics of small breast and/or ovarian cancer families with germline mutations in BRCA1 and BRCA2.携带BRCA1和BRCA2种系突变的小乳腺癌和/或卵巢癌家族的特征
Br J Cancer. 1999 Mar;79(9-10):1475-8. doi: 10.1038/sj.bjc.6690235.
10
BRCA1 and BRCA2 germline mutations in Uruguayan breast and breast-ovarian cancer families. Identification of novel mutations and unclassified variants.乌拉圭乳腺癌和乳腺癌-卵巢癌家族的 BRCA1 和 BRCA2 种系突变。新突变和未分类变异体的鉴定。
Breast Cancer Res Treat. 2011 Jul;128(1):211-8. doi: 10.1007/s10549-010-1320-2. Epub 2010 Dec 29.

引用本文的文献

1
Superior anti-tumor efficacy of diisopropylamine dichloroacetate compared with dichloroacetate in a subcutaneous transplantation breast tumor model.在皮下移植性乳腺肿瘤模型中,二异丙胺二氯乙酸盐相较于二氯乙酸盐具有更强的抗肿瘤疗效。
Oncotarget. 2016 Oct 4;7(40):65721-65731. doi: 10.18632/oncotarget.11609.
2
Recurrent BRCA1 and BRCA2 mutations in Mexican women with breast cancer.患有乳腺癌的墨西哥女性中BRCA1和BRCA2基因的复发性突变
Cancer Epidemiol Biomarkers Prev. 2015 Mar;24(3):498-505. doi: 10.1158/1055-9965.EPI-13-0980. Epub 2014 Nov 4.
3
Detection of inherited mutations for hereditary cancer using target enrichment and next generation sequencing.利用靶向富集和下一代测序技术检测遗传性癌症的遗传突变。
Fam Cancer. 2015 Mar;14(1):9-18. doi: 10.1007/s10689-014-9749-9.
4
Etiology of familial breast cancer with undetected BRCA1 and BRCA2 mutations: clinical implications.未检测到BRCA1和BRCA2突变的家族性乳腺癌的病因:临床意义。
Cell Oncol (Dordr). 2014 Feb;37(1):1-8. doi: 10.1007/s13402-013-0158-0. Epub 2013 Dec 4.
5
MicroRNA-based molecular classification of non-BRCA1/2 hereditary breast tumours.基于 microRNA 的非 BRCA1/2 遗传性乳腺癌肿瘤的分子分类。
Br J Cancer. 2013 Nov 12;109(10):2724-34. doi: 10.1038/bjc.2013.612. Epub 2013 Oct 8.
6
Genetics of disc-related disorders: current findings and lessons from other complex diseases.椎间盘相关疾病的遗传学:当前研究发现及其他复杂疾病的经验教训
Eur Spine J. 2014 Jun;23 Suppl 3:S354-63. doi: 10.1007/s00586-013-2878-2. Epub 2013 Jul 10.
7
Breast feeding, parity and breast cancer subtypes in a Spanish cohort.母乳喂养、生育次数与西班牙队列乳腺癌亚型的关系
PLoS One. 2012;7(7):e40543. doi: 10.1371/journal.pone.0040543. Epub 2012 Jul 11.
8
Family history and breast cancer hormone receptor status in a Spanish cohort.家族史与西班牙队列乳腺癌激素受体状态
PLoS One. 2012;7(1):e29459. doi: 10.1371/journal.pone.0029459. Epub 2012 Jan 6.
9
The pathology of hereditary breast cancer.遗传性乳腺癌的病理学
Hered Cancer Clin Pract. 2004 Jul 15;2(3):131-8. doi: 10.1186/1897-4287-2-3-131.
10
Genome-wide linkage scan reveals three putative breast-cancer-susceptibility loci.全基因组连锁扫描揭示了三个假定的乳腺癌易感基因座。
Am J Hum Genet. 2009 Feb;84(2):115-22. doi: 10.1016/j.ajhg.2008.12.013. Epub 2009 Jan 15.

本文引用的文献

1
Prevalence of BRCA1 and BRCA2 Jewish mutations in Spanish breast cancer patients.西班牙乳腺癌患者中BRCA1和BRCA2犹太突变的患病率。
Br J Cancer. 1999 Mar;79(7-8):1302-3. doi: 10.1038/sj.bjc.6690208.
2
Identification of the 185delAG BRCA1 mutation in a Spanish Gypsy population.西班牙吉普赛人群中185delAG BRCA1突变的鉴定。
Hum Genet. 1998 Dec;103(6):707-8. doi: 10.1007/s004390050895.
3
BRCA1 and BRCA2: from molecular genetics to clinical medicine.BRCA1和BRCA2:从分子遗传学至临床医学
J Clin Oncol. 1998 May;16(5):1969-77. doi: 10.1200/JCO.1998.16.5.1969.
4
Haplotype and phenotype analysis of nine recurrent BRCA2 mutations in 111 families: results of an international study.111个家族中9种复发性BRCA2突变的单倍型和表型分析:一项国际研究的结果
Am J Hum Genet. 1998 Jun;62(6):1381-8. doi: 10.1086/301885.
5
BRCA1 mutations and breast cancer in the general population: analyses in women before age 35 years and in women before age 45 years with first-degree family history.一般人群中的BRCA1突变与乳腺癌:对35岁之前的女性以及有一级家族史的45岁之前的女性的分析。
JAMA. 1998 Mar 25;279(12):922-9. doi: 10.1001/jama.279.12.922.
6
Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium.乳腺癌家族中BRCA1和BRCA2基因的遗传异质性及外显率分析。乳腺癌连锁协会。
Am J Hum Genet. 1998 Mar;62(3):676-89. doi: 10.1086/301749.
7
Molecular analysis of the six most recurrent mutations in the BRCA1 gene in 87 Spanish breast/ovarian cancer families.对87个西班牙乳腺癌/卵巢癌家族中BRCA1基因最常见的六种突变进行分子分析。
Cancer Lett. 1998 Jan 30;123(2):153-8. doi: 10.1016/s0304-3835(97)00416-3.
8
Germ-line BRCA1 mutations in women with sporadic breast cancer: clinical correlations.散发性乳腺癌女性的生殖系BRCA1突变:临床相关性
J Clin Oncol. 1998 Jan;16(1):115-20. doi: 10.1200/JCO.1998.16.1.115.
9
BRCA2 in American families with four or more cases of breast or ovarian cancer: recurrent and novel mutations, variable expression, penetrance, and the possibility of families whose cancer is not attributable to BRCA1 or BRCA2.美国家庭中出现四例或更多例乳腺癌或卵巢癌病例时的BRCA2:复发性和新的突变、可变表达、外显率,以及癌症不归因于BRCA1或BRCA2的家庭的可能性。
Am J Hum Genet. 1997 May;60(5):1031-40.
10
Population genetics of BRCA1 and BRCA2.BRCA1和BRCA2的群体遗传学
Am J Hum Genet. 1997 May;60(5):1013-20.